TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,786
|
1,120
|
3,674 |
| Financial expenses |
0
|
1
|
10 |
| Earnings before taxes |
7,134
|
3,296
|
4,677 |
| EBITDA |
6,880
|
3,234
|
5,570 |
| Total assets |
16,799
|
9,612
|
7,222 |
| Current assets |
13,949
|
6,564
|
3,291 |
| Current liabilities |
8,225
|
1,498
|
74 |
| Equity capital |
8,574
|
8,115
|
7,148 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.0%
|
84.4%
|
99.0% |
| Turnover per employee |
2,595
|
373
|
1,225 |
| Profit as a percentage of turnover |
91.6%
|
294.3%
|
127.3% |
| Return on assets (ROA) |
42.5%
|
34.3%
|
64.9% |
| Current ratio |
169.6%
|
438.2%
|
4447.3% |
| Return on equity (ROE) |
83.2%
|
40.6%
|
65.4% |
| Change turnover |
6,663
|
-2,256
|
1,184 |
| Change turnover % |
593%
|
-67%
|
48% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
200% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.